PRPO - トランスジェノミック （Precipio Inc.）

Customer to begin gradually onboarding panels in Q1-2023, potential $1.2M revenue at full capacity NEW HAVEN, Conn., Dec. 06, 2022 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) announced a 4-year agreement with a new customer to bring HemeScreen technology into their lab. Based on volume information provided by the customer, revenues in Q1-2023

Precipio, Inc. (NASDAQ:NASDAQ:PRPO) Q3 2022 Earnings Conference Call November 14, 2022 05:00 PM ET Company Participants Ilan Danieli - Chief Executive Officer Conference Call Participants…

Poster presents findings of a study of ~1000 patient samples demonstrating superior accuracy for HemeScreen MPN Assay NEW HAVEN, Conn., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) presented at the annual 2022 AMP conference a poster presentation of the results of a groundbreaking study, conducted in collaboration with faculty

US gold futures traded lower this morning on Friday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company''s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga''s insider transactions platform.3 Clear Channel Outdoor The Trade: Clear Channel Outdoor Holdings, Inc. (NYSE: CCO ) 10% owner Ares Partners Holdco LLC bought a total of 400,000 shares at an average price of $1.59. To … Full story available on Benzinga.com

Precipio Inc. (NASDAQ:PRPO) shares, rose in value on Friday, 09/16/22, with the stock price down by -9.08% to the previous day’s close as strong demand from buyers drove the stock to $0.95. Actively observing the price movement in the last trading, the stock closed the session at $1.04, falling within a range of $0.91 and … Thinking Of Buying Precipio Inc. (NASDAQ: PRPO) Stock? Here Is What You Should Know Read More »

US gold futures traded lower this morning on Friday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company''s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga''s insider transactions platform.3 Clear Channel Outdoor The Trade: Clear Channel Outdoor Holdings, Inc. (NYSE: CCO ) 10% owner Ares Partners Holdco LLC bought a total of 400,000 shares at an average price of $1.59. To … Full story available on Benzinga.com

Precipio Inc. (NASDAQ:PRPO) shares, rose in value on Friday, 09/16/22, with the stock price down by -9.08% to the previous day’s close as strong demand from buyers drove the stock to $0.95. Actively observing the price movement in the last trading, the stock closed the session at $1.04, falling within a range of $0.91 and … Thinking Of Buying Precipio Inc. (NASDAQ: PRPO) Stock? Here Is What You Should Know Read More »

During the last session, Precipio Inc. (NASDAQ:PRPO)’s traded shares were 3.01 million, with the beta value of the company hitting 2.08. At the end of the trading day, the stock’s price was $1.04, reflecting an intraday gain of 8.33% or $0.08. The 52-week high for the PRPO share is $3.13, that puts it down -200.96 … How Could You Make A Quick Recovery From Precipio Inc. (NASDAQ: PRPO) Given A -284.62% Drop From Highs? Read More »

Adding customer segment exceeding $100M in market potential Adding customer segment exceeding $100M in market potential

Adding customer segment exceeding $100M in market potential NEW HAVEN, Conn., Sept. 15, 2022 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), has signed a distribution agreement for HemeScreen with a major distribution partner (name withheld as per partner’s policy). Following an upcoming training program and onboarding of their national coverage,

Shares of specialty cancer diagnostics company Precipio (PRPO) have fallen 15.2% on Tuesday afternoon and, if losses hold, are on track to snap a four-session win streak, which…

Precipio press release (NASDAQ:PRPO): FY GAAP EPS of -$0.40.Revenue of $8.85M (+45.3% Y/Y).Shares -2.38% AH.

NEW HAVEN, Conn., March 22, 2022 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO ) , will be hosting its Q4-2021 and year end shareholder update call on Monday, April 4 th at 5:00 PM ET. The call will include updates on the Company''s current core businesses. The conference call may be accessed by calling 844-695-5519 (international callers dial 1-412-902-6760). All callers should ask for the Precipio Inc. conference call. Participants may also pre-register for the conference call at https://dpregister.com/sreg/10164970/f20eec96a8 . For those that pre-register for the shareholder call, the host service will send a calendar invitation and a direct dial-in number for the call to your email used during registration, which will allow for the registrant to bypass the operator. Listeners interested in submitting questions in advance should email their questions to investors@precipiodx.com and management will do its best to address those questions during the call.

Precipio (PRPO) said CFO Carl Iberger will resign, effective Mar. 21 for personal reasons.Matt Gage, director of financial reporting and analysis, has been promoted to interim CFO…